These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 16115142)
21. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia. Shiba N; Taki T; Park MJ; Shimada A; Sotomatsu M; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Arakawa H; Hayashi Y Br J Haematol; 2012 Feb; 156(3):413-4. PubMed ID: 21981547 [No Abstract] [Full Text] [Related]
22. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Wagner JE; Tolar J; Levran O; Scholl T; Deffenbaugh A; Satagopan J; Ben-Porat L; Mah K; Batish SD; Kutler DI; MacMillan ML; Hanenberg H; Auerbach AD Blood; 2004 Apr; 103(8):3226-9. PubMed ID: 15070707 [TBL] [Abstract][Full Text] [Related]
23. FANCD2: a branch-point in DNA damage response? Grompe M Nat Med; 2002 Jun; 8(6):555-6. PubMed ID: 12042798 [No Abstract] [Full Text] [Related]
24. Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children. Svojgr K; Sumerauer D; Puchmajerova A; Vicha A; Hrusak O; Michalova K; Malis J; Smisek P; Kyncl M; Novotna D; Machackova E; Jencik J; Pycha K; Vaculik M; Kodet R; Stary J Eur J Med Genet; 2016 Mar; 59(3):152-7. PubMed ID: 26657402 [TBL] [Abstract][Full Text] [Related]
25. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. Alter BP; Rosenberg PS; Brody LC J Med Genet; 2007 Jan; 44(1):1-9. PubMed ID: 16825431 [TBL] [Abstract][Full Text] [Related]
26. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia. Tischkowitz M; Ameziane N; Waisfisz Q; De Winter JP; Harris R; Taniguchi T; D'Andrea A; Hodgson SV; Mathew CG; Joenje H Br J Haematol; 2003 Nov; 123(3):469-71. PubMed ID: 14617007 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-2-induced graft-versus-leukemia for the treatment of AML in a BRCA2 Fanconi anemia patient. Yeo CJ; Gilman AL J Pediatr Hematol Oncol; 2014 Mar; 36(2):e78-80. PubMed ID: 23619121 [TBL] [Abstract][Full Text] [Related]
28. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Tischkowitz MD; Morgan NV; Grimwade D; Eddy C; Ball S; Vorechovsky I; Langabeer S; Stöger R; Hodgson SV; Mathew CG Leukemia; 2004 Mar; 18(3):420-5. PubMed ID: 14749703 [TBL] [Abstract][Full Text] [Related]
29. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732 [TBL] [Abstract][Full Text] [Related]
30. Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population. Ahmad F; Mandava S; Das BR Hematol Oncol; 2009 Jun; 27(2):90-7. PubMed ID: 19365794 [TBL] [Abstract][Full Text] [Related]
31. [Fanconi Anemia, Complementation Group D1 Caused by Biallelic Mutations of BRCA2 Gene--Case Report]. Puchmajerová A; Švojgr K; Novotná D; Macháčková E; Sumerauer D; Smíšek P; Kodet R; Kynčl M; Křepelová A; Foretová L Klin Onkol; 2016; 29 Suppl 1():S89-92. PubMed ID: 26691948 [TBL] [Abstract][Full Text] [Related]
33. A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia. Radulovic I; Kuechler A; Schündeln MM; Paulussen M; von Neuhoff N; Reinhardt D; Hanenberg H Eur J Med Genet; 2021 Aug; 64(8):104260. PubMed ID: 34118472 [TBL] [Abstract][Full Text] [Related]
34. A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay. Biswas K; Das R; Alter BP; Kuznetsov SG; Stauffer S; North SL; Burkett S; Brody LC; Meyer S; Byrd RA; Sharan SK Blood; 2011 Sep; 118(9):2430-42. PubMed ID: 21719596 [TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia. Markaki EA; Stiakaki E; Zafiropoulos A; Arvanitis DA; Katzilakis N; Dimitriou H; Spandidos DA; Kalmanti M Pediatr Blood Cancer; 2006 Jul; 47(1):14-21. PubMed ID: 16526056 [TBL] [Abstract][Full Text] [Related]
36. Increased frequency of Fanconi anemia group C genetic variants in children with sporadic acute myeloid leukemia. Awan A; Malcolm Taylor G; Gokhale DA; Dearden SP; Will A; Stevens RF; Birch JM; Eden T Blood; 1998 Jun; 91(12):4813-4. PubMed ID: 9616183 [No Abstract] [Full Text] [Related]
37. Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma. Smetsers S; Muter J; Bristow C; Patel L; Chandler K; Bonney D; Wynn RF; Whetton AD; Will AM; Rockx D; Joenje H; Strathdee G; Shanks J; Klopocki E; Gille JJ; Dorsman J; Meyer S Fam Cancer; 2012 Dec; 11(4):661-5. PubMed ID: 22829014 [TBL] [Abstract][Full Text] [Related]
38. Hepatoblastoma in a 4-year-old girl with Fanconi anaemia. Kopic S; Eirich K; Schuster B; Hanenberg H; Varon-Mateeva R; Rittinger O; Schimpl G; Schindler D; Jones N Acta Paediatr; 2011 May; 100(5):780-3. PubMed ID: 21138478 [TBL] [Abstract][Full Text] [Related]